Ketoacidosis in a diabetic patient associated with SARS-CoV-2 infection – Case report
Keywords:Diabetic Ketoacidosis; SARS-CoV-2; Diabetes Mellitus; Covid-19; Health teaching.
Report of a patient with type 1 diabetes mellitus presenting with severe diabetic ketoacidosis associate with SARS-CoV-2 infection under treatment in an Intensive Care Unit at a Hospital in the city of Manaus-AM. A 50-year-old male patient with previous diagnosis of Psoriasis Vulgaris and Type 1 Diabetes Mellitus, in regular use of Insulin, presented a flu-like syndrome manifested by fever, dyspnea, myalgia and anosmia. After five days evolved with worsening of breathing pattern associated with a decline in general condition. Subsequently diagnosed with Severe Ketoacidosis associated with SARS-CoV-2 infection, then admitted to an Intensive Care Unit bed, being discharged after 08 days of hospitalization with substantial improvement in the respiratory condition and resolution of ketoacidosis. The relationship between SARS-CoV-2 infection and the development of ketoacidosis in diabetic patients became clear, as well as the association between ICU care and better outcome.
Chan, K. H., Thimmareddygari, D., Ramahi, A., Atallah, L., Baranetsky, N. G., & Slim, J. (2020). Clinical characteristics and outcome in patients with combined diabetic ketoacidosis and hyperosmolar hyperglycemic state associated with COVID-19: A retrospective, hospital-based observational case series. Diabetes Research and Clinical Practice, 166. https://doi.org/10.1016/j.diabres.2020.108279
Chee, Y. J., Ng, S., & Yeoh, E. (2020). Diabetic ketoacidosis precipitated by Covid-19 in a patient with newly diagnosed diabetes mellitus. Diabetes research and clinical practice, 164, 108166. https://doi.org/10.1016/j.diabres.2020.108166
Goldman, N., Fink, D., Cai, J., Lee, Y. N., & Davies, Z. (2020). High prevalence of COVID-19-associated diabetic ketoacidosis in UK secondary care. Diabetes Research and Clinical Practice, 166. https://doi.org/10.1016/j.diabres.2020.108291
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N. H., Nitsche, A., Müller, M. A., Drosten, C., & Pöhlmann, S. (2020). SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell, 181(2), 271–280.e8. https://doi.org/10.1016/j.cell.2020.02.052
Huang, I., Lim, M. A., & Pranata R. (2020). Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia – a systematic review, meta-analysis, and meta-regression. Diabetes Metab Syndr, 14:395–403.
IDF - International Diabetes Federation. (2019). IDF Diabetes Atlas. 9. ed. Brussels (BEL).
Kitabchi, A. E., Umpierrez, G. E., Miles, J. M., & Fisher, J. N. (2009). Hyperglycemic crises in adult patients with diabetes. Diabetes care, 32(7), 1335–1343. https://doi.org/10.2337/dc09-9032
Li, J., Wang, X., Chen, J., Zuo, X., Zhang, H., & Deng, A. (2020). COVID-19 infection may cause ketosis and ketoacidosis. Diabetes, obesity & metabolism, 22(10), 1935–1941. https://doi.org/10.1111/dom.14057
Mauvais-Jarvis, F., Sobngwi, E., Porcher, R., Riveline, J. P., Kevorkian, J. P., Vaisse, C., Charpentier, G., Guillausseau, P. J., Vexiau, P., & Gautier, J. F. (2004). Ketosis-prone type 2 diabetes in patients of sub-Saharan African origin: clinical pathophysiology and natural history of beta-cell dysfunction and insulin resistance. Diabetes, 53(3), 645–653. https://doi.org/10.2337/diabetes.53.3.645
Nyenwe, E. A., & Kitabchi, A. E. (2016). The evolution of diabetic ketoacidosis: na update of its etiology, pathogenesis and management. Metabolism; 65(4):507-521.
Orioli, L., Hermans, M. P., Thissen, J. P., Maiter, D., Vandeleene, B., & Yombi, J. C. (2020). COVID-19 in diabetic patients: Related risks and specifics of management. Annales d'endocrinologie, 81(2-3), 101–109. https://doi.org/10.1016/j.ando.2020.05.001
Oyarzabal, I. M., García, C. B., Barrio, C. R., Torres, L. M., Gómez, G. A. L., González, C. I., Hermoso, L. F., Luzuriaga, T. C., Rica, E. I., López, G. M. J., & Rodríguez, R. M. (2012). Ketoacidosis at onset of type 1 diabetes mellitus in pediatric age in Spain and review of the literature. Pediatric endocrinology reviews: PER, 9(3), 669–671.
Pititto, B. A., & Ferreira, S. R. G. (2020). Diabetes and covid-19: more than the sum of two morbidities. Revista de Saúde Pública, v. 54 https://doi.org/10.11606/s1518-8787.2020054002577
Palermo, N. E., Sadhu, A. R., & McDonnell, M. E. (2020). Diabetic Ketoacidosis in COVID-19: Unique Concerns and Considerations. The Journal of clinical endocrinology and metabolism, 105(8), dgaa360. https://doi.org/10.1210/clinem/dgaa360
Santos, W. L., Laranjeira, D. B., Ribeiro, K. L., Cruz, K. O., Silva, S. S., Pacheco, E. V. F., & Oliveira Filho, W. (2022). SARS-CoV-2 infection in an insulin-dependent type I diabetic patient with subsequent ketoacidosis – Case Report. Research, Society and Development, 11(5), e32211528342. https://doi.org/10.33448/rsd-v11i5.28342
Tan, H., Wang, C., & Yu, Y. (2012). H1N1 influenza: the trigger of diabetic ketoacidosis in a young woman with ketosis-prone diabetes. Am J Med Sci.; 343(2):180-183.
Tay, M. Z., Poh, C. M., Rénia, L., MacAry, P. A., & Ng, L. F. P. (2020). The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol; 20:363–74. http://dx.doi.org/10.1038/s41577-020-0311-8.
Wyckoff, J., & Abrahamson, M. J. (2005). Diabetic ketoacidosis and hyperosmolar hyperglycemic state. ln: Joslin's Diabetes Mellitus, 14th ed., Philadelphia: Lippin cott Williams and Wilkins, p. 887-99.
World Health Organization. (2020). Naming the coronavirus disease (COVID-19) and the virus that causes it 2020 [31/03/2020]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it.
Zhou, J., & Tan J. (2020). Diabetes patients with COVID-19 need better blood glucose management in Wuhan, China. Metabolism. 107:154216. doi:10.1016/j.metabol.2020.154216.
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, M., Huang, B., Shi, W., Lu, R., Niu, P., Zhan, F., Ma, X., Wang, D., Xu, W., Wu, G., Gao, G. F., & Tan, W. (2020). A novel coronavirus from patients with pneumonia in China, 2019. The New England Journal of Medicine, 382:727-33. http://doi.org/10.1056/NEJMoa2001017
How to Cite
Copyright (c) 2022 Klender Luiz Ribeiro; Danillo Bezerra Laranjeira; William Leal dos Santos; Soraya Souto da Silva; Ketllyn de Oliveira Cruz; Erick Vinícius Fernandes Pacheco; Wilson de Oliveira Filho
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.